ARTICLE |
a Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania
b Department of Pediatrics, Morgan Stanley Children's Hospital of New York-Presbyterian and Columbia University Medical Center, New York, New York
c Department of Pediatrics, Steele Children's Research Center, University of Arizona, Tucson, Arizona
| ABSTRACT |
|---|
|
|
|---|
METHODS. We reviewed 1477 consecutive pediatric cardiopulmonary resuscitation index events (for patients younger than 18 years) submitted to the National Registry of Cardiopulmonary Resuscitation from January 2000 through July 2004. The primary outcome was survival to hospital discharge. Secondary outcomes included survival of event and neurologic outcome. Multivariable logistic regression was performed to analyze the association between calcium use and outcomes.
RESULTS. Calcium was used in 659 (45%) of 1477 events. Calcium was more likely to be used during cardiopulmonary resuscitation in the settings of pediatric facilities, ICUs, cardiac surgery, cardiopulmonary resuscitation duration of
15 minutes, asystole, and concurrently with other advanced life support medications: epinephrine, vasopressin, sodium bicarbonate, and magnesium sulfate. The use of calcium during cardiopulmonary resuscitation adjusted for confounding factors was associated with decreased survival to discharge and was not associated with favorable neurologic outcome.
CONCLUSIONS. Calcium is used frequently during in-hospital pediatric cardiopulmonary resuscitation. Although epidemiologic associations do not necessarily indicate causality, calcium use during cardiopulmonary resuscitation is associated with decreased survival to hospital discharge and unfavorable neurologic outcome.
Key Words: cardiopulmonary resuscitation pediatrics calcium survival
Abbreviations: CPR—cardiopulmonary resuscitation AHA—American Heart Association NRCPR—National Registry of Cardiopulmonary Resuscitation PCPC—pediatric cerebral performance category OR—odds ratio CI—confidence interval aOR—adjusted OR
The role of calcium administration during cardiopulmonary resuscitation (CPR) remains controversial. Although calcium ions play a critical role in myocardial contractile performance and impulse formation, limited retrospective and prospective studies of calcium administration during CPR have not shown any benefit.1–9 Furthermore, high serum calcium levels induced by calcium administration may be detrimental. Several studies have implicated cytoplasmic calcium accumulation in the final common pathway of cell death.10–13 Calcium accumulation results from calcium's entering cells after ischemia and during reperfusion of ischemic organs; increased cytoplasmic calcium concentration activates intracellular enzyme systems, resulting in cellular necrosis. In 2000, the American Heart Association (AHA) published guidelines limiting the recommended use of calcium to selected resuscitation circumstances: documented hypocalcemia, hyperkalemia, hypermagnesemia, and calcium channel blocker overdose.14 These guidelines also explicitly stated that calcium should not be used routinely to support circulation in the setting of cardiac arrest (class III recommendation: not useful and may cause harm).
Specific patterns of calcium use during in-hospital pediatric CPR, and their effect on survival have not been reported since these guidelines were published. Recently, a limited, single-center study reported an association between calcium use during CPR performed in the PICU and increased mortality.15 The National Registry of Cardiopulmonary Resuscitation (NRCPR) is a large, multicenter database that prospectively and rigorously documents adult and pediatric in-hospital cardiac arrests.16 We conducted this study using the NRCPR database to characterize patterns of calcium use during in-hospital pediatric CPR. We hypothesized that calcium continues to be used frequently during in-hospital pediatric CPR and that its use varies by hospital-specific, patient-specific, and event-specific characteristics. We also hypothesized that calcium use during in-hospital pediatric CPR is associated with worse survival to hospital discharge, and worse event survival and unfavorable neurologic outcome.
| METHODS |
|---|
|
|
|---|
Inclusion and Exclusion Criteria
Data were analyzed from 167 participating NRCPR hospitals that recorded cardiopulmonary arrests of patients who were younger than 18 years and provided >6 months of data from January 1, 2000, through July 31, 2004. All patients who were younger than 18 years and experienced cardiopulmonary arrest that required CPR at participating institutions were eligible for this study. An event was defined as an arrest that required chest compressions and/or defibrillation. An index event was defined as the patient's first cardiopulmonary arrest that required CPR during hospitalization. Only index events were eligible for inclusion in the study. Out-of-hospital arrests, arrests that occurred in the delivery room or NICU, arrests in patients with "do not attempt resuscitation" orders, and arrests that were resolved by implantable cardioverter-defibrillator shocks were excluded.
Outcome Measures
The prospectively selected primary outcome measure was survival to hospital discharge.17–19 The secondary outcome measures included survival of event (defined as return of spontaneous circulation for >20 minutes) and neurologic outcome. The neurologic outcome was determined according to the pediatric cerebral performance category (PCPC) scale as follows: (1) a normal neurologic state, (2) mild disability, (3) moderate disability, (4) severe disability, (5) coma or vegetative state, and (6) death.20,21 Neurologic status before the arrest and at discharge was determined by chart review. A favorable neurologic outcome was defined by a PCPC score of 1, 2, or 3 or no change from baseline PCPC scores.22
Statistical Analysis
All statistical analyses were performed with a commercially available statistical package (Stata 8, College Station, TX). Summary results are presented as means ± SD for variables that are distributed normally. Variables that were not distributed normally are presented as medians and interquartile ranges. Differences between groups were analyzed by the Wilcoxon rank-sum test for continuous variables and the
2 test for dichotomous variables. Hospital, patient, and event variables associated with calcium use by univariate analysis (P < .20) were included in stepwise multivariable logistic regression analysis. Finally, all factors associated with primary and secondary outcomes on univariate analysis (P < .20) were included in stepwise multivariable logistic regression to describe the association of calcium use with outcome measures adjusted for confounding factors. Odds ratios (ORs) with 95% confidence intervals (CIs) were reported. The sample size was not planned. All P values are 2-sided.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
The factors that were significantly associated with calcium use during in-hospital pediatric CPR after controlling for duration of CPR for
15 minutes by stepwise multivariable logistic regression are shown in Table 3. Calcium use during CPR was associated with arrests that occurred in pediatric facilities and ICUs. Notably, calcium use during CPR continued to demonstrate an independent association with asystole as the first documented rhythm during the arrest (adjusted OR [aOR]: 1.3; 95% CI: 1.1–1.8). In addition, use of calcium during CPR was independently associated with the concurrent use of other advanced life support medications.
|
15 minutes), calcium administration during CPR was independently associated with poor survival to discharge and unfavorable neurologic outcome after in-hospital pediatric CPR, as hypothesized (Table 4). Twenty-one percent of patients survived to discharge when calcium was used, compared with 44% who survived when calcium was not used (aOR: 0.6; 95% CI: 0.5–0.9). In addition, only 15% of patients had favorable neurologic outcome when calcium was administered during CPR, compared with 35% with favorable neurologic outcome when calcium was not administered (aOR: 0.6; 95% CI: 0.4–0.8).
|
Finally, we examined the effect of calcium administration on outcomes in patients who received CPR for <15 minutes (n = 501). After adjustment for potentially confounding factors, calcium use remained associated with worse survival to discharge (aOR: 0.7; 95% CI: 0.4–0.9) and was not associated with favorable neurologic outcome (aOR: 0.6; 95% CI: 0.3–0.9).
| DISCUSSION |
|---|
|
|
|---|
Previous studies of adults had speculated that calcium administration during CPR might benefit a subset of patients with asystole and pulseless electrical activity1,2; however, subsequent limited prospective and retrospective adult studies of calcium administration during resuscitation in these settings failed to demonstrate any benefit.3–7 Later studies that consisted of large prospective cohorts of adults who sustained both in-hospital and out-of-hospital cardiac arrests did not show any association between the use of standard advanced cardiac life support medications (including calcium) and survival.8,9 On the basis of these data, the AHA in 2000 issued advanced life support guidelines that recommended limiting the use of calcium to select resuscitation circumstances.14 Few pediatric studies have examined the effects of calcium administration during CPR on survival and neurologic outcome. de Mos et al15 reported the association of calcium administration during CPR with increased hospital mortality among 91 pediatric cardiac arrests in their PICU (aOR: 5.4; 95% CI: 1.1–25.0). The authors did not specifically account for factors associated with calcium use and speculated that this association might reflect increased arrest duration in nonsurvivors. Compared with our study, this single-center study included patients with nonperfusing rhythms only and had a greater proportion of postcardiac surgical patients. In addition to calcium use, risk factors that were associated with increase in hospital mortality included preexisting renal failure (aOR: 6.1; 95% C: 1.8–31) and being on epinephrine infusion at the time of arrest (aOR: 9.5; 95% CI: 1.5–62).15 A study that described the outcomes of in-hospital ventricular fibrillation in 859 children observed that calcium use during CPR was associated with reduced survival to discharge and poor neurologic outcome but did not specifically examine indications for calcium use or patterns of use during CPR.23 Our study has a much larger number of patients from multiple centers with multiple illness categories represented and thus lends itself to greater generalizability to in-hospital pediatric cardiac arrests across the United States.
Specific indications for calcium use during CPR (hyperkalemia, documented hypocalcemia, hypermagnesemia, and calcium channel blocker overdose) are captured in the NRCPR under the categories of metabolic/electrolyte abnormalities and toxicologic abnormalities. This study revealed that calcium was administered to 45% of children who were treated with CPR. The combined incidence of metabolic/electrolyte and toxicologic abnormalities (as both preexisting conditions and immediate precipitating causes) in the NRCPR database is only 25%. Also, calcium was administered in 49% of events with asystole and 42% of events with pulseless electrical activity. This suggests that calcium is often used in circumstances other than those recommended by the pediatric advanced life support guidelines. After publication of the guidelines in 2000, calcium use during in-hospital pediatric CPR decreased slightly from 50% to 42% of events the next year but since then has continued to range between 42% and 46% every year. This finding emphasizes that the published guidelines have had minimal impact on subsequent behavior and practice with regard to calcium administration during CPR.
There are several reasons that calcium might be used so frequently during CPR in children. In neonates and infants, the immature myocardium depends more on extracellular calcium levels because intracellular calcium stores are limited.24 This age group has significant risk factors such as cardiac bypass surgery, sepsis, and prematurity that have a significant impact on myocardial function and extracellular ionized calcium concentrations. Perhaps in part because of these factors, practitioners chose to provide calcium in 44% of events involving neonates and infants in this study. Nevertheless, in this age category, those who received calcium during CPR had worse survival to discharge (26%) compared with those who did not (55%; P < .001). Specifically, in the population of postcardiac surgical infants, after adjustment for confounding factors, the use of calcium during CPR was associated with worse event survival; however, calcium use during CPR was not significantly associated with reduced survival to hospital discharge (aOR: 0.6; 95% CI: 0.3–1.2) or unfavorable neurologic outcome (aOR: 0.6; 95% CI: 0.3–1.3). Additional studies are necessary to evaluate the impact of calcium administration during CPR in the postcardiac surgical infant and long-term outcomes.
The frequent use of calcium during CPR in other age and diagnostic categories may reflect medical futility and a "last-ditch" attempt to try all possible therapies during resuscitation. For example, calcium was administered during 56% of events that required CPR for
15 minutes, whereas it was used during 27% of events that required CPR for <15 minutes (P < .001). Calcium use in nonsurvivors to discharge was 53% compared with 28% in survivors to discharge (P < .001). Previous studies indicated that duration of CPR for >15 minutes was associated with poor outcomes from in-hospital pediatric CPR.23,25 Similarly, in this study, the median duration of CPR in nonsurvivors to discharge was 25 minutes (interquartile range: 12–45) compared with 12 minutes (interquartile range: 5–25) in those who survived to discharge (P < .001). In addition, in this study, calcium use during CPR was significantly associated with administration of other advanced cardiac life support medications, suggesting its use as part of the last-ditch resuscitative efforts. Irrespective of event duration, calcium use during CPR was associated with worse survival to discharge and unfavorable neurologic outcome. This finding has important implications because of the widely known role of calcium in mediating reperfusion injury in the setting of ischemia resulting in cell death.
An important limitation of the study results from the lack of explicit documentation of specific indications for calcium use and details of calcium dosing during CPR as captured in the NRCPR. A dose-response effect, if observed, could have provided stronger evidence for the effect of calcium administration on outcome. Another important limitation is the inability to adjust for variation in facility characteristics and physician and nurse staffing in different settings, resulting in our inability to use hierarchical cluster modeling. Other potential limitations pertain to the integrity and validity of the data and sampling bias. Uniform operational definitions, uniform data collection, rigorous abstractor training, detailed periodic reabstraction, and large sample size were instituted prospectively to address data integrity and validity. Sampling bias was minimized by the use of strict inclusion and exclusion criteria, comprehensive methods to verify all arrests as entered into the NRCPR, a large sample, and the multicenter design. Finally, it is possible that the existing NRCPR data elements fail to capture other, unmeasured confounders of outcomes, despite the use of suitable analytical techniques. Thus, the observed association between calcium use and poor outcomes may not necessarily reflect a causal relationship, and the possibility that calcium is used more often for children who have a lower probability of survival cannot be excluded.
This study has important implications. First, the results emphasize that calcium continues to be used frequently during in-hospital pediatric CPR, despite guidelines that recommend limiting the use of calcium to specific circumstances. Pediatric advanced life support guidelines published by the AHA in 2005 continue to restrict the use of calcium to specific circumstances, including hyperkalemia, documented hypocalcemia, hypermagnesemia, and calcium channel blocker overdose.25 Second, the use of calcium during CPR without such indications is associated with worse survival to discharge and unfavorable neurologic outcome, perhaps because of reperfusion injury to the ischemic brain, heart, and other organs mediated by calcium.
| CONCLUSIONS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
The AHA National Registry of Cardiopulmonary Resuscitation investigators include the authors and M. E. Mancini, M. A. Peberdy, E. Allen, R. S. Braithwaite, B. Eigel, E. Hunt, W. Kaye, G. L. Larkin, J. P. Ornato, G. Nichol, J. Potts, M. Smythe, and T. Lane-Truitt.
We gratefully acknowledge Charles Schleien, MD for research mentorship; Richard Lin, MD, Kathryn Roberts, RN, and Carey Roth-Bayer, PhD, for assistance; and all of the data abstractors, staff, and investigators who work so hard to contribute data to the AHA NRCPR.
| FOOTNOTES |
|---|
Address correspondence to Vijay Srinivasan, MD, Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104. E-mail: srinivasan{at}email.chop.edu
The authors have indicated they have no financial relationships relevant to this article to disclose.
| What's Known on This Subject The use of calcium administration during cardiac arrest is controversial. Since 2000, American Heart Association guidelines have limited use of calcium to specific circumstances during cardiac arrest: documented hypocalcemia, hyperkalemia, hypermagnesemia and calcium channel blocker overdose.
|
| What This Study Adds Published guidelines have had minimal impact on the frequency of calcium administration during in-hospital pediatric cardiac arrest. Calcium is often administered during cardiac arrest, even in circumstances where its use may be harmful and associated with worse outcomes.
|
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||